Chlorpromazine in treatment of acute pulmonary edema

[No abstract available

Hydatid disease presenting as cardiac tamponade - A case history

WOS: A1996UU58500009PubMed ID: 8678335Although hydatid disease has been reported in almost all human tissues, cardiac involvement is uncommon. The authors report a case of cardiac hydatid disease presenting with cardiac tamponade. The diagnostic value of transthoracic and transesophageal echocardiography, computed tomography, and angiography in hydatid heart disease is also discussed

Effect of the final coronary arterial diameter after coronary angioplasty on heart rate variability responses

PubMedID: 12049681Background: Autonomic nervous system dysfunction and reduced heart rate variability (HRV) after percutaneous transluminal coronary angioplasty (PTCA) were reported in patients with coronary artery disease. However, factors related to reduced HRV are not clearly demonstrated. The aim of the present study was to assess the relationship between HRV indices and the final coronary arterial luminal diameter after PTCA. Methods: Twenty-seven patients (23 male, 4 female, mean age: 52.5 ± 7.1 years) with single vessel disease were included in the study. PTCA was performed in all patients. Low-frequency power (LFP), high-frequency power (HFP), and total power (TP) were calculated by using frequency-domain analysis of HRV. All examinations were performed 24 hours before, and 24 hours, 10 days, and 30 days after PTCA. The patients were divided into groups according to the PTCA restenosis risk score, the degree of dilatation, and revascularization after coronary angioplasty. Results: The groups were comparable for age, gender, and coronary artery risk factors. HRV was found to be reduced in 76% of patients. Reduction in HRV after PTCA was significantly related to the PTCA risk score and the degree of revascularization (r = 0.48, P < 0.01 and r = 0.50, P < 0.008). Reduction in HRV was more significant in patients with previous myocardial infarction (P < 0.05). Recovery of HRV occurred on the tenth day after PTCA. Conclusion: Transient and rapidly recovered, especially parasympathetically modulated HRV reduction occurred after PTCA in patients with single-vessel disease. HRV reduction is associated with PTCA restenosis risk score and the degree of revascularization as invasive feature of angioplasty, hence it may be related to reperfusion

The effect of oral verapamil on ventricular irregularity and systolic time intervals in long-standing atrial fibrillation

[No abstract available

Dressler-like syndrome after percutaneous mitral balloon valvuloplasty pericarditis?

WOS: 000073417100032PubMed ID: 9600539

Hydatid disease presenting as cardiac tamponade: A case history

PubMedID: 8678335Although hydatid disease has been reported in almost all human tissues, cardiac involvement is uncommon. The authors report a case of cardiac hydatid disease presenting with cardiac tamponade. The diagnostic value of transthoracic and transesophageal echocardiography, computed tomography, and angiography in hydatid heart disease is also discussed

A serious complication of percutaneous mitral valvuloplasty: Systemic embolism. How can we decrease it?

WOS: A1996UA59800011PubMed ID: 8638873Systemic embolism is a potential and severe complication of percutaneous balloon mitral valvuloplasty (PBMV). The incidence of systemic embolism during PBMV has been reported to be less than 5% and only 0.6% with the Inoue technique. This is less than that reported in closed commissurotomy series and about the same as in open commissurotomy. In the authors' series of 50 cases, the incidence of systemic embolism was 2% (1 case). The patient had mitral restenosis (after closed commissurotomy) with mild to moderate valvular and subvalvular calcification, and cerebral embolism occurred during the procedure. To prevent systemic embolism, the authors' standard policy was to perform transesophageal echocardiography (TEE), computed tomography, and magnetic resonance imaging before the procedure and to give heparin during the procedure and two months preceding it in cases with atrial fibrillation or with a history of previous embolism and to limit manipulation of the catheter in the left atrium. The authors believe that a close scrutiny in the selection of patients, improved technology of the dilating system, good experience with PBMV, and adequate heparinization are also of great importance in the prevention of thromboembolic complications

Left ventricular systolic and diastolic functions in patients with sickle cell anemia

The aim of this study was to evaluate the left ventricular systolic and diastolic functions in patients with sickle cell anemia. Fifty-four patients (34 male, 20 female, mean age 22.6 ± 7.3 years) and 23 healthy persons (12 male, 11 female, mean age 26.7 ± 6.8 years) were studied. After clinical examination and routine biochemical evaluation by a hematologist, patients with sickle cell anemia were admitted to the study. M-mode and 2-dimensional and Doppler echocardiographic measurements of patients and controls were performed according to criteria of the American Echocardiography Society. The values of the patient groups were compared with the values of normal healthy subjects (controls). Left ventricular systolic and diastolic diameters of sickle cell patients were greater than those of controls (p < 0.001). All of the sickle cell anemia patients had reduced systolic cardiac function (EF: 0.57 ± 0.1 vs 0.63 ± 0.06 and FS: 0.30 ± 0.06 vs 0.34 ± 0.04, p < 0.02) and abnormal diastolic left ventricular function parameters compared with the control group (IRT: 114 ± 20 msec vs 65 ± 7 msec, p < 0.0001; E/A ratio: 1.2 ± 0.5 vs 1.6 ± 0.04, p < 0.01). Left ventricular mass (LVM) was greater in patients than in controls (222 ± 78 g vs 177 ± 46 g, p < 0.01). Left ventricular systolic and diastolic functions were abnormal in patients with sickle cell anemia, and the left ventricular mass was greater in the patients compared with controls

A serious complication of percutaneous mitral valvuloplasty: Systemic embolism. How can we decrease it? Case history

PubMedID: 8638873Systemic embolism is a potential and severe complication of percutaneous balloon mitral valvuloplasty (PBMV). The incidence of systemic embolism during PBMV has been reported to be less than 5% and only 0.6% with the Inoue technique. This is less than that reported in closed commissurotomy series and about the same as in open commissurotomy. In the authors' series of 50 cases, the incidence of systemic embolism was 2% (1 case). The patient had mitral restenosis (after closed commissurotomy) with mild to moderate valvular and subvalvular calcification, and cerebral embolism occurred during the procedure. To prevent systemic embolism, the authors' standard policy was to perform transesophageal echocardiography (TEE), computed tomography, and magnetic resonance imaging before the procedure and to give heparin during the procedure and two months preceding it in cases with atrial fibrillation or with a history of previous embolism and to limit manipulation of the catheter in the left atrium. The authors believe that a close scrutiny in the selection of patients, improved technology of the dilating system, good experience with PBMV, and adequate heparinization are also of great importance in the prevention of thromboembolic complications

Comparative assessment of the effects of vasodilators on peripheral vascular reactivity in patients with systemic scleroderma and Raynaud's phenomenon: Color Doppler flow imaging study

PubMedID: 8644944The aim of the present study was assessment of peripheral vascular reactivity during cold test and effects of different types of vasodilators on vascular resistance in patients with progressive systemic sclerosis and Raynaud's phenomenon with use of color Doppler flow imaging of upper extremity